Biomarker for Friedreich's Ataxia (BioFridA)
NCT04548921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-08-03
Summary
International, multicenter, observational, longitudinal monitoring study to identify biomarker/s for Friedreich's Ataxia and to explore the clinical robustness, specificity, and long-term variability of these biomarker/s
Conditions
- FXN Gene
- FRDA
- Hereditary Diseases
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. Dr. · CENTOGENE GmbH
Eligibility
- Min Age
- 2 Months
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Lebanon
Study Locations
More Related Trials
-
A National Retrospective Population Based Cohort Study of the Natural History of Ataxia Telangiectasia
NCT04991701 ·Status: UNKNOWN
-
Identification of Biomarkers in Spinocerebellar Ataxia 3
NCT03885167 ·Status: COMPLETED
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT03225144 ·Status: RECRUITING
-
Biomarkers in Concussion
NCT05943561 ·Status: UNKNOWN
-
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850 ·Status: RECRUITING
-
Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis
NCT02058732 ·Status: TERMINATED ·Phase: NA
-
Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
NCT06516016 ·Status: NOT_YET_RECRUITING
-
Natural History and Disease Progression Biomarkers of Multiple System Atrophy
NCT04229173 ·Status: COMPLETED ·Phase: NA
-
FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study
NCT03920358 ·Status: ACTIVE_NOT_RECRUITING
-
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 ·Status: ENROLLING_BY_INVITATION
-
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
NCT04680130 ·Status: ENROLLING_BY_INVITATION
-
123I-ALTROPANE® Reference Image Acquisition in Subjects With Diagnostically Uncertain Tremor
NCT00596908 ·Status: COMPLETED
-
Natural History Study of Patients with HPDL Mutations
NCT05848271 ·Status: RECRUITING
-
Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
NCT00739518 ·Status: COMPLETED ·Phase: NA
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1
-
Natural History Characterization in Symptomatic and Asymptomatic Progranuline Gene Mutation Carriers
NCT04014673 ·Status: COMPLETED ·Phase: NA
-
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
NCT01592552 ·Status: COMPLETED
-
GENetic Fronto Temporal Dementia Initiative in Lille
NCT04639622 ·Status: RECRUITING ·Phase: NA
-
Neurofilament Surveillance Project (NSP)
NCT04516499 ·Status: ACTIVE_NOT_RECRUITING
-
Glymphatic Pathway in Brain Imaging
NCT05035251 ·Status: RECRUITING
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
NCT05409989 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MRI Biomarkers in ALS
NCT02405182 ·Status: COMPLETED
-
Clearance Mechanisms in Atypical Neurodegenerative Diseases
NCT05317871 ·Status: UNKNOWN
-
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
NCT05988073 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
NCT01886820 ·Status: UNKNOWN ·Phase: PHASE3